The bidirectional association between atrial fibrillation and myocardial infarction

[1]  Tracy Y. Wang,et al.  Characteristics, Process Metrics, and Outcomes Among Patients With ST-Elevation Myocardial Infarction in Rural vs Urban Areas in the US: A Report From the US National Cardiovascular Data Registry. , 2022, JAMA cardiology.

[2]  T. Therneau,et al.  The Utility of Multistate Models: A Flexible Framework for Time-to-Event Data , 2022, Current Epidemiology Reports.

[3]  Fatemeh Rajati,et al.  The long-term effect of exposure to respirable particulate matter on the incidence of myocardial infarction: a systematic review and meta-analysis study , 2022, Environmental Science and Pollution Research.

[4]  Mary E. Haas,et al.  Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease , 2022, JAMA network open.

[5]  Changfa Guo,et al.  Coronary Artery Disease and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study , 2022, Journal of cardiovascular development and disease.

[6]  O. Arah,et al.  Conceptualizing, Contextualizing, and Operationalizing Race in Quantitative Health Sciences Research , 2022, The Annals of Family Medicine.

[7]  C. Schooling,et al.  Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes , 2021, Scientific Reports.

[8]  L. Køber,et al.  Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study. , 2021, European heart journal.

[9]  L. Lind,et al.  Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings , 2021, Open Heart.

[10]  E. Benjamin,et al.  Social determinants of atrial fibrillation , 2021, Nature Reviews Cardiology.

[11]  H. Calkins,et al.  Inflammation, atrial fibrillation, and the potential role for colchicine therapy , 2021, Heart rhythm O2.

[12]  Liangrong Zheng,et al.  The Association Between Ambient Air Pollution and Atrial Fibrillation. , 2021, International heart journal.

[13]  J. Pell,et al.  Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies. , 2021, European journal of preventive cardiology.

[14]  L. Fauchier,et al.  Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis , 2021, Clinical Research in Cardiology.

[15]  P. Sanders,et al.  Self-reported Physical Activity and Atrial Fibrillation Risk: A Systematic Review and Meta-analysis. , 2020, Heart rhythm.

[16]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[17]  T. Assimes,et al.  Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study , 2020, bioRxiv.

[18]  G. Davey Smith,et al.  A phenome-wide bidirectional Mendelian randomization analysis of atrial fibrillation , 2020, medRxiv.

[19]  Baoxin Liu,et al.  Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  Si‐Hyuck Kang,et al.  New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke , 2020, BMJ Open.

[21]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[22]  Deepak L. Bhatt,et al.  2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[23]  Jianhong Wu,et al.  Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017 , 2020, European heart journal. Quality of care & clinical outcomes.

[24]  Baoxin Liu,et al.  Long‐term impact of new‐onset atrial fibrillation complicating acute myocardial infarction on heart failure , 2020, ESC heart failure.

[25]  L. Roever,et al.  Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction. , 2020, European journal of preventive cardiology.

[26]  E. Svennberg,et al.  Short-term associations between ambient air pollution and acute atrial fibrillation episodes. , 2020, Environment international.

[27]  S. Larsson,et al.  Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study , 2020, International journal of cancer.

[28]  Shiming Liu,et al.  Aspirin-omitted dual antithrombotic therapy in nonvalvular atrial fibrillation patients presenting with acute coronary syndrome or undergoing percutaneous coronary intervention: results of a meta-analysis. , 2020, European heart journal. Cardiovascular pharmacotherapy.

[29]  Deepak L. Bhatt,et al.  Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. , 2020, JAMA cardiology.

[30]  Frederick T. Han,et al.  P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis , 2020, Heart.

[31]  Sang Min Park,et al.  Association of smoking cessation after atrial fibrillation diagnosis on the risk of cardiovascular disease: a cohort study of South Korean men , 2020, BMC public health.

[32]  I. Porto,et al.  Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[34]  A. Furber,et al.  De novo atrial fibrillation as an independent prognostic marker after ST-segment elevation myocardial infarction: Results from the RIMA registry. , 2019, Journal of cardiology.

[35]  Alan D. Lopez,et al.  Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study , 2019, BMC Medicine.

[36]  N. Jones,et al.  Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis , 2019, Heart.

[37]  G. Davey Smith,et al.  Commentary: Orienting causal relationships between two phenotypes using bidirectional Mendelian randomization. , 2019, International journal of epidemiology.

[38]  M. Ezekowitz,et al.  Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry). , 2019, The American journal of cardiology.

[39]  L. Chen,et al.  Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation , 2019, bioRxiv.

[40]  Chee-Jen Chang,et al.  Adverse Outcomes Associated with Pre-Existing and New-Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome: A Retrospective Cohort Study , 2019, Cardiology and Therapy.

[41]  A. Jaffe,et al.  Type 2 Myocardial Infarction: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[42]  M. Perez,et al.  No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation , 2019, Diabetologia.

[43]  G. Hindricks,et al.  Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[44]  E. Riboli,et al.  Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies , 2018, European journal of preventive cardiology.

[45]  T. Gerds,et al.  Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.

[46]  K. Lunetta,et al.  Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study , 2018, British Medical Journal.

[47]  M. de Melis,et al.  Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[48]  D. Holmes,et al.  Coronary Embolus: An Underappreciated Cause of Acute Coronary Syndromes. , 2018, JACC. Cardiovascular interventions.

[49]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[50]  A. Garg,et al.  Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  George Davey Smith,et al.  Recent Developments in Mendelian Randomization Studies , 2017, Current Epidemiology Reports.

[52]  V. Howard,et al.  Comparison of Risk of Atrial Fibrillation Among Employed Versus Unemployed (from the REasons for Geographic and Racial Differences in Stroke Study). , 2017, The American journal of cardiology.

[53]  H. Bøtker,et al.  Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study. , 2017, International journal of cardiology.

[54]  A. Brandes,et al.  Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation. , 2017, Journal of the American College of Cardiology.

[55]  T. Edvardsen,et al.  Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.

[56]  S. Nattel.  Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation. , 2017, JACC. Clinical electrophysiology.

[57]  E. Varol,et al.  The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction , 2017, Scandinavian journal of clinical and laboratory investigation.

[58]  R. Bai,et al.  Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis. , 2016, Atherosclerosis.

[59]  I. Janszky,et al.  Weight and weight change and risk of acute myocardial infarction and heart failure – the HUNT Study , 2016, Journal of internal medicine.

[60]  L. Zhong,et al.  Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials. , 2016, International journal of cardiology.

[61]  L. Chen,et al.  Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study. , 2016, JAMA cardiology.

[62]  E. Ohman,et al.  Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. , 2016, Journal of the American College of Cardiology.

[63]  K. Silventoinen,et al.  Disentangling the relative importance of different socioeconomic resources for myocardial infarction incidence and survival: a longitudinal study of over 300,000 Finnish adults. , 2016, European journal of public health.

[64]  I. Janszky,et al.  Alcohol consumption is associated with a lower incidence of acute myocardial infarction: results from a large prospective population‐based study in Norway , 2016, Journal of internal medicine.

[65]  M. Ezekowitz,et al.  Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. , 2015, American heart journal.

[66]  David M. Evans,et al.  Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. , 2015, Annual review of genomics and human genetics.

[67]  P. Rautava,et al.  Association of age and gender with risk for non-ST-elevation myocardial infarction , 2015, European journal of preventive cardiology.

[68]  Yenn-Jiang Lin,et al.  Inflammation and the pathogenesis of atrial fibrillation , 2015, Nature Reviews Cardiology.

[69]  R. Virmani,et al.  Sex differences in coronary artery disease: pathological observations. , 2015, Atherosclerosis.

[70]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[71]  E. Soliman,et al.  Atrial Fibrillation and Incident Myocardial Infarction in the Elderly , 2014, Clinical cardiology.

[72]  T. Chao,et al.  Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. , 2014, Heart rhythm.

[73]  P. Rautava,et al.  Gender, age and risk of ST segment elevation myocardial infarction , 2014, European journal of clinical investigation.

[74]  L. Chen,et al.  Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study). , 2014, The American journal of cardiology.

[75]  S. Larsson,et al.  Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. , 2014, Journal of the American College of Cardiology.

[76]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[77]  M. Almendro-Delia,et al.  Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry , 2014, European heart journal. Acute cardiovascular care.

[78]  E. Benjamin,et al.  Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. , 2014, European heart journal.

[79]  David M Herrington,et al.  Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.

[80]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[81]  O. Franco,et al.  Unrecognized myocardial infarction and risk of atrial fibrillation: the Rotterdam Study. , 2013, International journal of cardiology.

[82]  Y. Hao,et al.  Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation. , 2013, International journal of cardiology.

[83]  Paul L. Hess,et al.  Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. , 2013, The American journal of medicine.

[84]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[85]  A. Pupi,et al.  Detection of infarct size safety threshold for left ventricular ejection fraction impairment in acute myocardial infarction successfully treated with primary percutaneous coronary intervention , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[86]  Jagmeet P. Singh,et al.  Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[87]  M. Niemelä,et al.  Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention. , 2012, The American journal of cardiology.

[88]  W. Abhayaratna,et al.  Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. , 2011, Heart rhythm.

[89]  A. Capucci,et al.  A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[90]  Thomas Lumley,et al.  Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation , 2010, Journal of General Internal Medicine.

[91]  N. Keenan,et al.  Acute myocardial infarction hospitalization in the United States, 1979 to 2005. , 2010, The American journal of medicine.

[92]  R. Konwar,et al.  Reinventing the ACE inhibitors: some old and new implications of ACE inhibition , 2010, Hypertension Research.

[93]  P. Armstrong,et al.  Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. , 2009, European heart journal.

[94]  D. Roden,et al.  Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. , 2009, American heart journal.

[95]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[96]  W. Markiewicz,et al.  Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. , 2007, The American journal of cardiology.

[97]  G. Breithardt,et al.  Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. , 2007, European heart journal.

[98]  J. McMurray,et al.  Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. , 2005, Journal of the American College of Cardiology.

[99]  A. Maggioni,et al.  Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data , 2001, Heart.

[100]  V. Salomaa,et al.  Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study , 2001, Journal of epidemiology and community health.

[101]  L. Køber,et al.  The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. , 1999, European heart journal.

[102]  U. Goldbourt,et al.  Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction , 1992 .

[103]  R. S. Eliot,et al.  ARRHYTHMIAS IN ACUTE MYOCARDIAL INFARCTION. , 1964, Diseases of the chest.

[104]  L. Katz,et al.  RECENT MYOCARDIAL INFARCTION: An Analysis of Five Hundred and Seventy-Two Cases , 1947 .

[105]  S. A. Levine,et al.  PROGNOSTIC VALUE OF VARIOUS CLINICAL AND ELECTROCARDIOGRAPHIC FEATURES OF ACUTE MYOCARDIAL INFARCTION: II. ULTIMATE PROGNOSIS , 1941 .

[106]  A. Master,et al.  DISTURBANCES OF RATE AND RHYTHM IN ACUTE CORONARY ARTERY THROMBOSIS , 1937 .